{"entity":{"type":"insider","cik":"0001919480","url":"/insider/0001919480","json_url":"/insider/0001919480.json","name":"Casdin Private Growth Equity Fund II GP, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":52,"n_filings":22,"first":"2023-05-19","last":"2025-12-04","span_basis":"filed_date"},"name_variants":[{"name":"Casdin Private Growth Equity Fund II GP, LLC","source":"filing","n_filings":22,"first_seen":"2023-05-19","last_seen":"2025-12-04"}],"transactions":[{"id":4295167,"accession":"0000919574-25-007243","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-25-007243","line_url":"/filing/0000919574-25-007243#line-3","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Eli; Casdin Private Growth Equity Fund II, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Partners Master Fund, L.P.; Casdin Partners GP, LLC; Casdin Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":1.4468,"price_display":"1.45","price_state":"stated","total_value":217020.0,"total_display":"217,020.00","shares_owned_after":72100000.0,"shares_owned_after_display":"72,100,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-04","filed_date":"2025-12-04","scope":"insider"},{"id":4295163,"accession":"0000919574-25-007243","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-25-007243","line_url":"/filing/0000919574-25-007243#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Eli; Casdin Private Growth Equity Fund II, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Partners Master Fund, L.P.; Casdin Partners GP, LLC; Casdin Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":75000.0,"shares_display":"75,000","price_per_share":1.4405,"price_display":"1.44","price_state":"stated","total_value":108037.5,"total_display":"108,037.50","shares_owned_after":71950000.0,"shares_owned_after_display":"71,950,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-03","filed_date":"2025-12-04","scope":"insider"},{"id":4295156,"accession":"0000919574-25-007243","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-25-007243","line_url":"/filing/0000919574-25-007243#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Eli; Casdin Private Growth Equity Fund II, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Partners Master Fund, L.P.; Casdin Partners GP, LLC; Casdin Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":125000.0,"shares_display":"125,000","price_per_share":1.4201,"price_display":"1.42","price_state":"stated","total_value":177512.5,"total_display":"177,512.50","shares_owned_after":71875000.0,"shares_owned_after_display":"71,875,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-02","filed_date":"2025-12-04","scope":"insider"},{"id":4192710,"accession":"0000919574-25-007187","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-25-007187","line_url":"/filing/0000919574-25-007187#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund, L.P.; Casdin Partners Master Fund, L.P.; Casdin Capital, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Eli; Casdin Partners GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7550000.0,"shares_display":"7,550,000","price_per_share":1.3031,"price_display":"1.30","price_state":"stated","total_value":9838405.0,"total_display":"9,838,405.00","shares_owned_after":71750000.0,"shares_owned_after_display":"71,750,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-25","filed_date":"2025-11-26","scope":"insider"},{"id":4192708,"accession":"0000919574-25-007187","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-25-007187","line_url":"/filing/0000919574-25-007187#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund, L.P.; Casdin Partners Master Fund, L.P.; Casdin Capital, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Eli; Casdin Partners GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":1.4325,"price_display":"1.43","price_state":"stated","total_value":214875.0,"total_display":"214,875.00","shares_owned_after":64200000.0,"shares_owned_after_display":"64,200,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-24","filed_date":"2025-11-26","scope":"insider"},{"id":4978493,"accession":"0000919574-25-007124","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-25-007124","line_url":"/filing/0000919574-25-007124#line-3","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund II GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund II, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Partners GP, LLC; Casdin Eli; Casdin Private Growth Equity Fund, L.P.; Casdin Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":450000.0,"shares_display":"450,000","price_per_share":1.3028,"price_display":"1.30","price_state":"stated","total_value":586260.0,"total_display":"586,260.00","shares_owned_after":64050000.0,"shares_owned_after_display":"64,050,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-20","filed_date":"2025-11-20","scope":"insider"},{"id":4978489,"accession":"0000919574-25-007124","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-25-007124","line_url":"/filing/0000919574-25-007124#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund II GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund II, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Partners GP, LLC; Casdin Eli; Casdin Private Growth Equity Fund, L.P.; Casdin Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":350000.0,"shares_display":"350,000","price_per_share":1.2826,"price_display":"1.28","price_state":"stated","total_value":448910.0,"total_display":"448,910.00","shares_owned_after":63600000.0,"shares_owned_after_display":"63,600,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-19","filed_date":"2025-11-20","scope":"insider"},{"id":4978477,"accession":"0000919574-25-007124","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-25-007124","line_url":"/filing/0000919574-25-007124#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund II GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund II, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Partners GP, LLC; Casdin Eli; Casdin Private Growth Equity Fund, L.P.; Casdin Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":275000.0,"shares_display":"275,000","price_per_share":1.2342,"price_display":"1.23","price_state":"stated","total_value":339405.0,"total_display":"339,405.00","shares_owned_after":63250000.0,"shares_owned_after_display":"63,250,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-18","filed_date":"2025-11-20","scope":"insider"},{"id":4698311,"accession":"0000919574-25-007087","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-25-007087","line_url":"/filing/0000919574-25-007087#line-3","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Partners GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Eli; Casdin Private Growth Equity Fund, L.P.; Casdin Capital, LLC; Casdin Partners Master Fund, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":225000.0,"shares_display":"225,000","price_per_share":1.2248,"price_display":"1.22","price_state":"stated","total_value":275580.0,"total_display":"275,580.00","shares_owned_after":62975000.0,"shares_owned_after_display":"62,975,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-17","filed_date":"2025-11-17","scope":"insider"},{"id":4698305,"accession":"0000919574-25-007087","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-25-007087","line_url":"/filing/0000919574-25-007087#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Partners GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Eli; Casdin Private Growth Equity Fund, L.P.; Casdin Capital, LLC; Casdin Partners Master Fund, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":1.2392,"price_display":"1.24","price_state":"stated","total_value":309800.0,"total_display":"309,800.00","shares_owned_after":62750000.0,"shares_owned_after_display":"62,750,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-14","filed_date":"2025-11-17","scope":"insider"},{"id":4698299,"accession":"0000919574-25-007087","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-25-007087","line_url":"/filing/0000919574-25-007087#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Partners GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Eli; Casdin Private Growth Equity Fund, L.P.; Casdin Capital, LLC; Casdin Partners Master Fund, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":450000.0,"shares_display":"450,000","price_per_share":1.2031,"price_display":"1.20","price_state":"stated","total_value":541395.0,"total_display":"541,395.00","shares_owned_after":62500000.0,"shares_owned_after_display":"62,500,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-13","filed_date":"2025-11-17","scope":"insider"},{"id":4192704,"accession":"0000919574-25-006597","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000919574-25-006597","line_url":"/filing/0000919574-25-006597#line-4","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund II, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund, L.P.; Casdin Eli; Casdin Capital, LLC; Casdin Partners GP, LLC; Casdin Private Growth Equity Fund II GP, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":375000.0,"shares_display":"375,000","price_per_share":1.1889,"price_display":"1.19","price_state":"stated","total_value":445837.5,"total_display":"445,837.50","shares_owned_after":62050000.0,"shares_owned_after_display":"62,050,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-12","filed_date":"2025-11-12","scope":"insider"},{"id":4192696,"accession":"0000919574-25-006597","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-25-006597","line_url":"/filing/0000919574-25-006597#line-3","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund II, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund, L.P.; Casdin Eli; Casdin Capital, LLC; Casdin Partners GP, LLC; Casdin Private Growth Equity Fund II GP, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300000.0,"shares_display":"300,000","price_per_share":1.196,"price_display":"1.20","price_state":"stated","total_value":358800.0,"total_display":"358,800.00","shares_owned_after":61675000.0,"shares_owned_after_display":"61,675,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-11","filed_date":"2025-11-12","scope":"insider"},{"id":4192689,"accession":"0000919574-25-006597","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-25-006597","line_url":"/filing/0000919574-25-006597#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund II, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund, L.P.; Casdin Eli; Casdin Capital, LLC; Casdin Partners GP, LLC; Casdin Private Growth Equity Fund II GP, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":275000.0,"shares_display":"275,000","price_per_share":1.1706,"price_display":"1.17","price_state":"stated","total_value":321915.0,"total_display":"321,915.00","shares_owned_after":61375000.0,"shares_owned_after_display":"61,375,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-10","filed_date":"2025-11-12","scope":"insider"},{"id":4192684,"accession":"0000919574-25-006597","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-25-006597","line_url":"/filing/0000919574-25-006597#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund II, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund, L.P.; Casdin Eli; Casdin Capital, LLC; Casdin Partners GP, LLC; Casdin Private Growth Equity Fund II GP, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":225000.0,"shares_display":"225,000","price_per_share":1.1234,"price_display":"1.12","price_state":"stated","total_value":252765.0,"total_display":"252,765.00","shares_owned_after":61100000.0,"shares_owned_after_display":"61,100,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-07","filed_date":"2025-11-12","scope":"insider"},{"id":5022109,"accession":"0000919574-25-005636","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-25-005636","line_url":"/filing/0000919574-25-005636#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund, L.P.; Casdin Private Growth Equity Fund II, L.P.; Casdin Eli; Casdin Capital, LLC; Casdin Private Growth Equity Fund II GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Partners GP, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":1.2892,"price_display":"1.29","price_state":"stated","total_value":128920.0,"total_display":"128,920.00","shares_owned_after":60875000.0,"shares_owned_after_display":"60,875,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-09","filed_date":"2025-09-11","scope":"insider"},{"id":4612851,"accession":"0000919574-25-005603","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-25-005603","line_url":"/filing/0000919574-25-005603#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund, L.P.; Casdin Partners Master Fund, L.P.; Casdin Capital, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Eli; Casdin Partners GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":1.2774,"price_display":"1.28","price_state":"stated","total_value":319350.0,"total_display":"319,350.00","shares_owned_after":60775000.0,"shares_owned_after_display":"60,775,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-04","filed_date":"2025-09-05","scope":"insider"},{"id":4612846,"accession":"0000919574-25-005603","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-25-005603","line_url":"/filing/0000919574-25-005603#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund, L.P.; Casdin Partners Master Fund, L.P.; Casdin Capital, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Eli; Casdin Partners GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":1.2656,"price_display":"1.27","price_state":"stated","total_value":316400.0,"total_display":"316,400.00","shares_owned_after":60525000.0,"shares_owned_after_display":"60,525,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-03","filed_date":"2025-09-05","scope":"insider"},{"id":4192618,"accession":"0000919574-25-005152","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-25-005152","line_url":"/filing/0000919574-25-005152#line-3","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Private Growth Equity Fund II, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Partners GP, LLC; Casdin Capital, LLC; Casdin Eli","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":125000.0,"shares_display":"125,000","price_per_share":1.2635,"price_display":"1.26","price_state":"stated","total_value":157937.5,"total_display":"157,937.50","shares_owned_after":60275000.0,"shares_owned_after_display":"60,275,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-26","filed_date":"2025-08-26","scope":"insider"},{"id":4192615,"accession":"0000919574-25-005152","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-25-005152","line_url":"/filing/0000919574-25-005152#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Private Growth Equity Fund II, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Partners GP, LLC; Casdin Capital, LLC; Casdin Eli","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":1.2409,"price_display":"1.24","price_state":"stated","total_value":248180.0,"total_display":"248,180.00","shares_owned_after":60150000.0,"shares_owned_after_display":"60,150,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-25","filed_date":"2025-08-26","scope":"insider"},{"id":4192610,"accession":"0000919574-25-005152","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-25-005152","line_url":"/filing/0000919574-25-005152#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Private Growth Equity Fund II, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Partners GP, LLC; Casdin Capital, LLC; Casdin Eli","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":1.2634,"price_display":"1.26","price_state":"stated","total_value":252680.0,"total_display":"252,680.00","shares_owned_after":59950000.0,"shares_owned_after_display":"59,950,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-22","filed_date":"2025-08-26","scope":"insider"},{"id":4904502,"accession":"0000919574-25-004979","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-25-004979","line_url":"/filing/0000919574-25-004979#line-3","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Partners GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Private Growth Equity Fund II, L.P.; Casdin Eli; Casdin Capital, LLC; Casdin Private Growth Equity Fund II GP, LLC; Casdin Partners Master Fund, L.P.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":1.2214,"price_display":"1.22","price_state":"stated","total_value":183210.0,"total_display":"183,210.00","shares_owned_after":59750000.0,"shares_owned_after_display":"59,750,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-15","filed_date":"2025-08-15","scope":"insider"},{"id":4904498,"accession":"0000919574-25-004979","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-25-004979","line_url":"/filing/0000919574-25-004979#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Partners GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Private Growth Equity Fund II, L.P.; Casdin Eli; Casdin Capital, LLC; Casdin Private Growth Equity Fund II GP, LLC; Casdin Partners Master Fund, L.P.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":133220.0,"shares_display":"133,220","price_per_share":1.2126,"price_display":"1.21","price_state":"stated","total_value":161542.572,"total_display":"161,542.57","shares_owned_after":59600000.0,"shares_owned_after_display":"59,600,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-14","filed_date":"2025-08-15","scope":"insider"},{"id":4904494,"accession":"0000919574-25-004979","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-25-004979","line_url":"/filing/0000919574-25-004979#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Partners GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Private Growth Equity Fund II, L.P.; Casdin Eli; Casdin Capital, LLC; Casdin Private Growth Equity Fund II GP, LLC; Casdin Partners Master Fund, L.P.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":75000.0,"shares_display":"75,000","price_per_share":1.3104,"price_display":"1.31","price_state":"stated","total_value":98280.0,"total_display":"98,280.00","shares_owned_after":59466780.0,"shares_owned_after_display":"59,466,780","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-13","filed_date":"2025-08-15","scope":"insider"},{"id":4657646,"accession":"0000919574-25-001777","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000919574-25-001777","line_url":"/filing/0000919574-25-001777#line-4","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund II, L.P.; Casdin Eli; Casdin Capital, LLC; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Partners GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4820959.0,"shares_display":"4,820,959","price_per_share":1.065,"price_display":"1.06","price_state":"stated","total_value":5134321.335,"total_display":"5,134,321.34","shares_owned_after":58846780.0,"shares_owned_after_display":"58,846,780","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-28","filed_date":"2025-03-04","scope":"insider"},{"id":2976271,"accession":"0000919574-24-005134","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-005134","line_url":"/filing/0000919574-24-005134#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Capital, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Private Growth Equity Fund II, L.P.; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP; Casdin Private Growth Equity Fund II GP, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":2.187,"price_display":"2.19","price_state":"stated","total_value":546750.0,"total_display":"546,750.00","shares_owned_after":54025821.0,"shares_owned_after_display":"54,025,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-27","filed_date":"2024-08-29","scope":"insider"},{"id":2300369,"accession":"0000919574-24-004878","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-24-004878","line_url":"/filing/0000919574-24-004878#line-3","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Eli; Casdin Private Growth Equity Fund II, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP; Casdin Partners GP, LLC; Casdin Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":2.1497,"price_display":"2.15","price_state":"stated","total_value":322455.0,"total_display":"322,455.00","shares_owned_after":53775821.0,"shares_owned_after_display":"53,775,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-26","filed_date":"2024-08-26","scope":"insider"},{"id":2300365,"accession":"0000919574-24-004878","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-24-004878","line_url":"/filing/0000919574-24-004878#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Eli; Casdin Private Growth Equity Fund II, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP; Casdin Partners GP, LLC; Casdin Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":292100.0,"shares_display":"292,100","price_per_share":2.1259,"price_display":"2.13","price_state":"stated","total_value":620975.39,"total_display":"620,975.39","shares_owned_after":53625821.0,"shares_owned_after_display":"53,625,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-23","filed_date":"2024-08-26","scope":"insider"},{"id":2300361,"accession":"0000919574-24-004878","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-004878","line_url":"/filing/0000919574-24-004878#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Eli; Casdin Private Growth Equity Fund II, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP; Casdin Partners GP, LLC; Casdin Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":307900.0,"shares_display":"307,900","price_per_share":1.9578,"price_display":"1.96","price_state":"stated","total_value":602806.62,"total_display":"602,806.62","shares_owned_after":53333721.0,"shares_owned_after_display":"53,333,721","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-22","filed_date":"2024-08-26","scope":"insider"},{"id":2138859,"accession":"0000919574-24-004812","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-24-004812","line_url":"/filing/0000919574-24-004812#line-3","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Capital, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":1.9039,"price_display":"1.90","price_state":"stated","total_value":951950.0,"total_display":"951,950.00","shares_owned_after":53025821.0,"shares_owned_after_display":"53,025,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-21","filed_date":"2024-08-21","scope":"insider"},{"id":2138856,"accession":"0000919574-24-004812","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-24-004812","line_url":"/filing/0000919574-24-004812#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Capital, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":1.8734,"price_display":"1.87","price_state":"stated","total_value":936700.0,"total_display":"936,700.00","shares_owned_after":52525821.0,"shares_owned_after_display":"52,525,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-20","filed_date":"2024-08-21","scope":"insider"},{"id":2138853,"accession":"0000919574-24-004812","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-004812","line_url":"/filing/0000919574-24-004812#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Capital, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":1.8529,"price_display":"1.85","price_state":"stated","total_value":463225.0,"total_display":"463,225.00","shares_owned_after":52025821.0,"shares_owned_after_display":"52,025,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-19","filed_date":"2024-08-21","scope":"insider"},{"id":2233686,"accession":"0000919574-24-004802","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-004802","line_url":"/filing/0000919574-24-004802#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund II, L.P.; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Eli; Casdin Capital, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1200000.0,"shares_display":"1,200,000","price_per_share":1.5946,"price_display":"1.59","price_state":"stated","total_value":1913520.0,"total_display":"1,913,520.00","shares_owned_after":51775821.0,"shares_owned_after_display":"51,775,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-16","scope":"insider"},{"id":3246153,"accession":"0000919574-24-004593","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-24-004593","line_url":"/filing/0000919574-24-004593#line-3","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Capital, LLC; Casdin Eli; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P.; Casdin Private Growth Equity Fund II GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Partners GP, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":550000.0,"shares_display":"550,000","price_per_share":1.6192,"price_display":"1.62","price_state":"stated","total_value":890560.0,"total_display":"890,560.00","shares_owned_after":50575821.0,"shares_owned_after_display":"50,575,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-13","filed_date":"2024-08-13","scope":"insider"},{"id":3246149,"accession":"0000919574-24-004593","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-24-004593","line_url":"/filing/0000919574-24-004593#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Capital, LLC; Casdin Eli; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P.; Casdin Private Growth Equity Fund II GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Partners GP, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":1.6412,"price_display":"1.64","price_state":"stated","total_value":820600.0,"total_display":"820,600.00","shares_owned_after":50025821.0,"shares_owned_after_display":"50,025,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-12","filed_date":"2024-08-13","scope":"insider"},{"id":3246145,"accession":"0000919574-24-004593","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-004593","line_url":"/filing/0000919574-24-004593#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Capital, LLC; Casdin Eli; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P.; Casdin Private Growth Equity Fund II GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Partners GP, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":525408.0,"shares_display":"525,408","price_per_share":1.6149,"price_display":"1.61","price_state":"stated","total_value":848481.3792,"total_display":"848,481.38","shares_owned_after":49525821.0,"shares_owned_after_display":"49,525,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-09","filed_date":"2024-08-13","scope":"insider"},{"id":3246141,"accession":"0000919574-24-004339","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-24-004339","line_url":"/filing/0000919574-24-004339#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Eli; Casdin Private Growth Equity Fund II GP, LLC; Casdin Partners GP, LLC; Casdin Capital, LLC; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP; Casdin Private Growth Equity Fund II, L.P.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":569562.0,"shares_display":"569,562","price_per_share":1.6374,"price_display":"1.64","price_state":"stated","total_value":932600.8188,"total_display":"932,600.82","shares_owned_after":49000413.0,"shares_owned_after_display":"49,000,413","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-08","filed_date":"2024-08-09","scope":"insider"},{"id":3246135,"accession":"0000919574-24-004339","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-004339","line_url":"/filing/0000919574-24-004339#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Eli; Casdin Private Growth Equity Fund II GP, LLC; Casdin Partners GP, LLC; Casdin Capital, LLC; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP; Casdin Private Growth Equity Fund II, L.P.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":1.5724,"price_display":"1.57","price_state":"stated","total_value":786200.0,"total_display":"786,200.00","shares_owned_after":48430821.0,"shares_owned_after_display":"48,430,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-07","filed_date":"2024-08-09","scope":"insider"},{"id":2846973,"accession":"0000919574-24-004280","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-24-004280","line_url":"/filing/0000919574-24-004280#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P.; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP; Casdin Eli; Casdin Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":1.5839,"price_display":"1.58","price_state":"stated","total_value":316780.0,"total_display":"316,780.00","shares_owned_after":47930821.0,"shares_owned_after_display":"47,930,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-05","filed_date":"2024-08-06","scope":"insider"},{"id":2846970,"accession":"0000919574-24-004280","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-004280","line_url":"/filing/0000919574-24-004280#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P.; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Amplify Fund, LP; Casdin Eli; Casdin Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000000.0,"shares_display":"1,000,000","price_per_share":1.6319,"price_display":"1.63","price_state":"stated","total_value":1631900.0,"total_display":"1,631,900.00","shares_owned_after":47730821.0,"shares_owned_after_display":"47,730,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-02","filed_date":"2024-08-06","scope":"insider"},{"id":2579704,"accession":"0000919574-24-003356","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-003356","line_url":"/filing/0000919574-24-003356#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Partners FO1-MSV, LP; Casdin Eli; Casdin Private Growth Equity Fund, L.P.; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund II GP, LLC; Casdin Partners GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Partners Master Fund, L.P.; Casdin Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":2.6,"price_display":"2.60","price_state":"stated","total_value":260000.0,"total_display":"260,000.00","shares_owned_after":46075821.0,"shares_owned_after_display":"46,075,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-23","filed_date":"2024-05-28","scope":"insider"},{"id":2035282,"accession":"0000919574-24-003308","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-24-003308","line_url":"/filing/0000919574-24-003308#line-3","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Eli; Casdin Private Growth Equity Fund II GP, LLC; Casdin Partners GP, LLC; Casdin Partners FO1-MSV, LP; Casdin Capital, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund II, L.P.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":2.5849,"price_display":"2.58","price_state":"stated","total_value":387735.0,"total_display":"387,735.00","shares_owned_after":45975821.0,"shares_owned_after_display":"45,975,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-22","filed_date":"2024-05-22","scope":"insider"},{"id":2035281,"accession":"0000919574-24-003308","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-24-003308","line_url":"/filing/0000919574-24-003308#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Eli; Casdin Private Growth Equity Fund II GP, LLC; Casdin Partners GP, LLC; Casdin Partners FO1-MSV, LP; Casdin Capital, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund II, L.P.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":350000.0,"shares_display":"350,000","price_per_share":2.5598,"price_display":"2.56","price_state":"stated","total_value":895930.0,"total_display":"895,930.00","shares_owned_after":45825821.0,"shares_owned_after_display":"45,825,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-21","filed_date":"2024-05-22","scope":"insider"},{"id":2035280,"accession":"0000919574-24-003308","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-003308","line_url":"/filing/0000919574-24-003308#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Eli; Casdin Private Growth Equity Fund II GP, LLC; Casdin Partners GP, LLC; Casdin Partners FO1-MSV, LP; Casdin Capital, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund II, L.P.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":2.5813,"price_display":"2.58","price_state":"stated","total_value":258130.0,"total_display":"258,130.00","shares_owned_after":45475821.0,"shares_owned_after_display":"45,475,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-20","filed_date":"2024-05-22","scope":"insider"},{"id":2079554,"accession":"0000919574-24-003252","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-24-003252","line_url":"/filing/0000919574-24-003252#line-3","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund II GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Capital, LLC; Casdin Eli; Casdin Partners Master Fund, L.P.; Casdin Partners GP, LLC; Casdin Partners FO1-MSV, LP; Casdin Private Growth Equity Fund, L.P.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":352072.0,"shares_display":"352,072","price_per_share":2.5621,"price_display":"2.56","price_state":"stated","total_value":902043.6712,"total_display":"902,043.67","shares_owned_after":45375821.0,"shares_owned_after_display":"45,375,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-17","filed_date":"2024-05-17","scope":"insider"},{"id":2079549,"accession":"0000919574-24-003252","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-24-003252","line_url":"/filing/0000919574-24-003252#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund II GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Capital, LLC; Casdin Eli; Casdin Partners Master Fund, L.P.; Casdin Partners GP, LLC; Casdin Partners FO1-MSV, LP; Casdin Private Growth Equity Fund, L.P.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":2.5419,"price_display":"2.54","price_state":"stated","total_value":1270950.0,"total_display":"1,270,950.00","shares_owned_after":45023749.0,"shares_owned_after_display":"45,023,749","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-16","filed_date":"2024-05-17","scope":"insider"},{"id":2079546,"accession":"0000919574-24-003252","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-003252","line_url":"/filing/0000919574-24-003252#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund II GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Capital, LLC; Casdin Eli; Casdin Partners Master Fund, L.P.; Casdin Partners GP, LLC; Casdin Partners FO1-MSV, LP; Casdin Private Growth Equity Fund, L.P.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":2.5651,"price_display":"2.57","price_state":"stated","total_value":1282550.0,"total_display":"1,282,550.00","shares_owned_after":44523749.0,"shares_owned_after_display":"44,523,749","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-15","filed_date":"2024-05-17","scope":"insider"},{"id":2300357,"accession":"0000919574-24-001888","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000919574-24-001888","line_url":"/filing/0000919574-24-001888#line-2","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Partners Master Fund, L.P.; Casdin Partners GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Partners FO1-MSV, LP; Casdin Private Growth Equity Fund II GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Capital, LLC; Casdin Eli; Casdin Private Growth Equity Fund II, L.P.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1403.0,"shares_display":"1,403","price_per_share":2.615,"price_display":"2.62","price_state":"stated","total_value":3668.845,"total_display":"3,668.84","shares_owned_after":11497928.0,"shares_owned_after_display":"11,497,928","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-05","filed_date":"2024-03-06","scope":"insider"},{"id":2300350,"accession":"0000919574-24-001888","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000919574-24-001888","line_url":"/filing/0000919574-24-001888#line-1","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Partners Master Fund, L.P.; Casdin Partners GP, LLC; Casdin Private Growth Equity Fund, L.P.; Casdin Partners FO1-MSV, LP; Casdin Private Growth Equity Fund II GP, LLC; CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Capital, LLC; Casdin Eli; Casdin Private Growth Equity Fund II, L.P.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":2.57,"price_display":"2.57","price_state":"stated","total_value":642500.0,"total_display":"642,500.00","shares_owned_after":11496525.0,"shares_owned_after_display":"11,496,525","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-04","filed_date":"2024-03-06","scope":"insider"},{"id":8352302,"accession":"0000919574-23-003425","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000919574-23-003425","line_url":"/filing/0000919574-23-003425#line-3","is_derivative":false,"issuer_cik":"0001162194","issuer_name":"STANDARD BIOTOOLS INC.","issuer_ticker":"LAB","issuer_name_source":null,"issuer_url":"/issuer/0001162194","owner_cik":null,"owner_name":"Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Partners FO1-MSV, LP; Casdin Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800000.0,"shares_display":"800,000","price_per_share":2.2949,"price_display":"2.29","price_state":"stated","total_value":1835920.0,"total_display":"1,835,920.00","shares_owned_after":1200000.0,"shares_owned_after_display":"1,200,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-19","filed_date":"2023-05-19","scope":"insider"}],"next_cursor":"2023-05-19|8352302","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001162194","name":"STANDARD BIOTOOLS INC.","url":"/issuer/0001162194","role":"Director","n_filings":22,"first_seen":"2023-05-19","last_seen":"2025-12-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001919480","retrieved_at":"2026-08-21T12:26:25+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}